Arrow Mark Colorado Holdings LLC Liquidia Corp Transaction History

Arrow Mark Colorado Holdings LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.6 - $5.79 $4.93 Million - $11 Million	-1,894,471 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.34 - $8.28 $247,310 - $471,827	-56,984 Reduced 2.92%	1,894,471 $9.32 Million
Q2 2020 Aug 14, 2020	BUY	$4.86 - $11.44 $1.42 Million - $3.35 Million	292,970 Added 17.66%	1,951,455 $16.4 Million
Q4 2019 Feb 14, 2020	BUY	$3.07 - $5.11 $194,030 - $322,962	63,202 Added 3.96%	1,658,485 $7.09 Million
Q3 2019 Nov 14, 2019	BUY	$3.29 - $8.24 $740,937 - $1.86 Million	225,209 Added 16.44%	1,595,283 $5.68 Million
Q2 2019 Aug 14, 2019	BUY	$7.92 - $11.39 $366,553 - $527,151	46,282 Added 3.5%	1,370,074 $11 Million
Q1 2019 May 15, 2019	BUY	$10.82 - $21.79 $6.65 Million - $13.4 Million	614,715 Added 86.69%	1,323,792 $15.1 Million
Q4 2018 Feb 14, 2019	BUY	$16.38 - $37.18 $569,925 - $1.29 Million	34,794 Added 5.16%	709,077 $15.4 Million
Q3 2018 Nov 14, 2018	BUY	$10.96 - $28.9 $7.39 Million - $19.5 Million	674,283 New	674,283 $18.5 Million

171

44.3M

1.55M

1.52M

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $724M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.